AblePrint Technology Co., Ltd. (TPEX:7734)

Market Cap	30.31B
Revenue (ttm)	1.88B
Net Income (ttm)	848.40M
Shares Out	28.06M
EPS (ttm)	33.16
PE Ratio	32.57
Forward PE	44.90
Dividend	17.09 (1.56%)
Ex-Dividend Date	Jul 29, 2025

Volume	471,704
Average Volume	226,715
Open	1,120.00
Previous Close	1,080.00
Day's Range	1,105.00 - 1,185.00
52-Week Range	632.17 - 1,560.51
Beta	n/a
RSI	60.52
Earnings Date	Aug 11, 2025

About Theseus Pharmaceuticals

AblePrint Technology Co., Ltd. operates as a process solution provider for reducing process issues for various industries in Taiwan and internationally. It solves various issues, such as void elimination, void-free soldering, heat dissipation, high-temperature reflow soldering, and package warpage suppression, as well as offers production and cost-saving solutions. The company also provides process solution regulations, including pneumatic and thermal process, process performance integration, and automation system solutions. It serves semicondu...

• Industry: Packaging & Containers
• Sector: Consumer Discretionary
• Founded: 1996
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7734

Financial Performance

In 2024, AblePrint Technology's revenue was 1.80 billion, an increase of 51.86% compared to the previous year's 1.19 billion. Earnings were 893.77 million, an increase of 62.96%.